Stocks
FibroGen (FGEN) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -186.3 | -288.5 | -288.5 | -282.8 | -259.3 | -139.3 | ||
| Changes by years, y/y, % | +153% | +55% | 0% | -2% | -8% | +28.1% | |||
FibroGen. EBITDA US GAAP, bln rub
FibroGen. EBITDA US GAAP, changes, %
FibroGen. EBITDA US GAAP, sum by quarters, bln rub
FibroGen (FGEN) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -85.4 | -46.6 | -52.3 | -30.2 | -10.1 | -139.3 | |
| Changes by years, y/y, % | +21% | -49% | -16% | -60% | -88% | |||
| Changes by quarters, q/q, % | +14% | -45% | +12% | -42% | -66% | |||
